Impact of injecting drug use on the interruption of antiretroviral therapies.
Muga
R
R
Servicio de Medicina Interna, 4a planta, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. rmuga@ns.hugtip.scs.es
Egea
J M
JM
Sanvisens
A
A
Arnal
J
J
Tural
C
C
Tor
J
J
Rey-Joly
C
C
D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000706:statistics & numerical data*; D018791:CD4 Lymphocyte Count; D003430:Cross-Sectional Studies; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006556:Heroin Dependence / Q000150:complications*; D006801:Humans; D008297:Male; D010342:Patient Acceptance of Health Care; D013030:Spain; D015819:Substance Abuse, Intravenous / Q000150:complications*; D017211:Treatment Failure; D019562:Viral Load